期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Role of genetics in the diagnosis and prognosis of Crohn's disease 被引量:8
1
作者 Epameinondas V Tsianos Konstantinos H Katantions Vasileios E Tsianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第48期5246-5259,共14页
Considering the epidemiological, genetic and immunological data, we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment inte... Considering the epidemiological, genetic and immunological data, we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact to produce the disease. It is probable that patients have a genetic predisposition for the development of the disease coupled with disturbances in immunoregulation. Several genes have so far been related to the diagnosis of Crohn's disease. These genes are related to innate pattern recognition receptors, to epithelial barrier homeostasis and maintenance of epithelial barrier integrity, to autophagy and to lymphocyte differentiation. So far, the strongest and most replicated associations with Crohn's disease have been demonstrated with NOD2 , IL23R and ATG16L1 genes. Many genes have so far been implicated in the prognosis of Crohn's disease and many attempts have been made for classification of genetic profiles in Crohn's disease.CARD15 seems to be not only a susceptibility gene, but also a disease-modifier gene for Crohn's disease. Enriching our understanding of Crohn's disease genetics is of value, but when combining genetic data with functional data the outcome could be of major importance to clinicians. 展开更多
关键词 Crohn's disease GENETICS POLYMORPHISM Diagnosis PROGNOSIS Genome-wide scan Genetic consortium
下载PDF
Role of genetics in the diagnosis and prognosis of Crohn's disease 被引量:4
2
作者 Epameinondas V Tsianos Konstantinos H Katsanos Vasileios E Tsianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第2期105-118,共14页
Considering epidemiological,genetic and immunological data,we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact t... Considering epidemiological,genetic and immunological data,we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact to produce the disease.It is probable that patients have a genetic predisposition for the development of the disease coupled with disturbances in immunoregulation.Several genes have been so far related to the diagnosis of Crohn's disease.Those genes are related to innate pattern recognition receptors,to epithelial barrier homeostasis and maintenance of epithelial barrier integrity,to autophagy and to lymphocyte differentiation.So far,the most strong and replicated associations with Crohn's disease have been done with NOD2,IL23R and ATG16L1 genes.Many genes have so far been implicated in prognosis of Crohn's disease and many attempts have been made to classify genetic profiles in Crohn's disease.CARD15 seems not only a susceptibility gene,but also a disease-modifier gene for Crohn's disease.Enriching our understanding on Crohn's disease genetics is important but when combining genetic data with functional data the outcome could be of major importance to clinicians. 展开更多
关键词 Crohn's GENETICS POLYMORPHISM Diagnosis Prognosis Genome wide scan Genetic consortium
下载PDF
Role of endoscopic retrograde cholangiopancreatography in pancreatic diseases 被引量:3
3
作者 Dimitrios K Christodoulou Epameinondas V Tsianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第38期4755-4761,共7页
Over the last 15 years,endoscopic retrograde cholangiopancreatography (ERCP) has evolved from a diagnostic tool to one that is primarily used to provide therapy. This development occurred f irst for biliary disorders ... Over the last 15 years,endoscopic retrograde cholangiopancreatography (ERCP) has evolved from a diagnostic tool to one that is primarily used to provide therapy. This development occurred f irst for biliary disorders and subsequently to a lesser extent for pancreatic diseases. Computed tomography, magnetic resonance imaging,magnetic resonance cholangiopancreatography and endoscopic ultrasonography suggest a diagnosis in the majority of patients with pancreatic diseases today and can help physicians and patients avoid unnecessary ERCP. However, a selected number of patients with pancreatic diseases may benef it from pancreatic endotherapy and avoid complex surgery and chronic use of medications. Pancreatic sphincterotomy, pancreatic stenting and pancreatic cyst drainage are some of the most effective and challenging endoscopic pancreatic interventions and should be performed with caution by expert therapeutic endoscopists.There has been a paucity of randomized studies investigating endoscopic techniques in comparison with surgery and medical therapy for the treatment of most benign and malignant pancreatic disorders due to the limited number of patients and the expertise required to attempt these procedures. 展开更多
关键词 Endoscopic retrograde cholangiopancreatography PANCREAS Pancreatic disease Pancreatic endotherapy Therapeutic endoscopy
下载PDF
von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis 被引量:1
4
作者 Georgios N Kalambokis Gerasimos Baltayiannis Dimitrios Christodoulou 《World Journal of Gastroenterology》 SCIE CAS 2016年第19期4786-4788,共3页
Increased thrombotic potential within the liver sinusoids due to local endothelial production of von Willebrand factor antigen macromolecules could represent an additional therapeutic target of portal hypertension in ... Increased thrombotic potential within the liver sinusoids due to local endothelial production of von Willebrand factor antigen macromolecules could represent an additional therapeutic target of portal hypertension in patients with cirrhosis. In this case, anti-inflammatory and antithrombotic drugs could modulate portal pressure by preventing the formation of intrahepatic platelet-induced microthrombi. 展开更多
关键词 von Willebrand factor ANTIGEN ENDOTHELIAL DYSFUNCTION Treatment PORTAL HYPERTENSION
下载PDF
Haemodynamic and renal effects of tadalafil in patients with cirrhosis
5
作者 Georgios N Kalambokis Paraskevi Kosta +1 位作者 Konstantinos Pappas Epameinondas V Tsianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第39期5009-5010,共2页
A recent report introduced the phosphodiesterase-5 inhibition by vardenafil as a novel treatment of portal hypertension in patients with cirrhosis.In the herein presented"letter to the editor",the administra... A recent report introduced the phosphodiesterase-5 inhibition by vardenafil as a novel treatment of portal hypertension in patients with cirrhosis.In the herein presented"letter to the editor",the administration of tadalafil did not influence portal haemodynamics but impaired systemic haemodynamics in patients with cirrhosis.Our observations concur with the results of a report in a previous issue of World Journal of Gastroenterology(October 2008).Moreover,tadalafil adversely affected renal function in patients with decompensated liver disease. 展开更多
关键词 TADALAFIL Portal hypertension CIRRHOSIS ASCITES Phosphodiesterase-5 inhibition
下载PDF
Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome 被引量:4
6
作者 George N Kalambokis Konstantinos Pappas Epameinondas V Tsianos 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2012年第4期434-437,共4页
Terlipressin has been shown to improve both pulmonary and systemic hemodynamics in stable cirrhotic patients with pulmonary hypertension,whereas other vasoconstrictors may cause pulmonary pressures to deteriorate We i... Terlipressin has been shown to improve both pulmonary and systemic hemodynamics in stable cirrhotic patients with pulmonary hypertension,whereas other vasoconstrictors may cause pulmonary pressures to deteriorate We investigated the pulmonary and systemic hemodynamic effects of the first terlipressin dose(2 mg) in 7 cirrhotic patients with PH presenting with variceal bleeding(n=4) or hepatorenal syndrome(n=3).Terlipressin decreased pulmonary vascular resistance(158.8±8.9 vs 186.5±13.9 dynes sec cm-5 ;P=0.003) together with an increase in systemic vascular resistance(2143± 126 vs 1643±126 dynes sec cm-5 ;P<0.001).Terlipressin should be the vasoconstrictor treatment of choice when patients present with variceal bleeding or HRS. 展开更多
关键词 terlipressin pulmonary hypertension CIRRHOSIS variceal bleeding hepatorenal syndrome
下载PDF
The conflict on posttreatment Lyme disease syndrome: a clinical mini review
7
作者 Manos Bogdos Sotirios Giannopoulos Maria Kosmidou 《Neuroimmunology and Neuroinflammation》 2016年第1期10-13,共4页
Is Borrelia burgdorferi responsible for the persistence of symptoms after the standard successful course of antibiotics in Lyme disease patients?This highly controversial issue,concerning the underlying mechanism of p... Is Borrelia burgdorferi responsible for the persistence of symptoms after the standard successful course of antibiotics in Lyme disease patients?This highly controversial issue,concerning the underlying mechanism of posttreatment Lyme disease syndrome(PTLDS),still seems to be a matter of intense conflict of opinion.PTLDS is the manifestation of nonspecific symptoms including fatigue,musculoskeletal pain,dysesthesias,and neurocognitive deterioration after the standard antimicrobial therapy administered to patients suffering from Lyme disease.In this article,we review the conflicting views and published highlights of recent human studies regarding PTLDS. 展开更多
关键词 Antibiotic therapy duration of therapy Lyme disease nonspecific symptoms posttreatment Lyme disease syndrome
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部